[1]
F. M. A. Alrofie and A. H. . Arbab, “Retrospective Comparison of Efficacy and Safety of Basiliximab and Antithymocyte Globulin in Kidney Transplant Recipients”, KJPS, vol. 1, no. 1, Aug. 2021.